BioAtla
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioAtla and other ETFs, options, and stocks.About BCAB
BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021.
CEOJay M. Short
CEOJay M. Short
Employees76
Employees76
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2007
Founded2007
Employees76
Employees76
BCAB Key Statistics
Market cap21.93M
Market cap21.93M
Price-Earnings ratio-0.35
Price-Earnings ratio-0.35
Dividend yield—
Dividend yield—
Average volume2.53M
Average volume2.53M
High today$0.4051
High today$0.4051
Low today$0.3647
Low today$0.3647
Open price$0.3967
Open price$0.3967
Volume1.38M
Volume1.38M
52 Week high$1.43
52 Week high$1.43
52 Week low$0.24
52 Week low$0.24
Stock Snapshot
With a market cap of 21.93M, BioAtla(BCAB) trades at $0.37. The stock has a price-to-earnings ratio of -0.35.
On 2026-01-09, BioAtla(BCAB) stock traded between a low of $0.36 and a high of $0.41. Shares are currently priced at $0.37, which is +1.7% above the low and -8.4% below the high.
BioAtla(BCAB) shares are trading with a volume of 1.38M, against a daily average of 2.53M.
During the past year, BioAtla(BCAB) stock moved between $0.24 at its lowest and $1.43 at its peak.
During the past year, BioAtla(BCAB) stock moved between $0.24 at its lowest and $1.43 at its peak.
People also own
Based on the portfolios of people who own BCAB. This list is generated using Robinhood data, and it’s not a recommendation.